Metraipolis › archive › dc_e46dca0e1967

Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40962832
DOI
10.1038/s41380-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T21:34:13.926Z
SHA-256 of the archived text
cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3
Stable URL of this page
https://metraipolis.com/documento/dc_e46dca0e1967

How to cite

Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832 — Europe PMC (en), https://europepmc.org/article/MED/40962832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e46dca0e1967 (Metraipolis archive dc_e46dca0e1967, sha256 cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3)
BibTeX
@misc{dce46dca0e1967,
  title = {Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40962832},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e46dca0e1967; sha256 cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40962832. Agents can read the archived copy with the MCP tool read_document.